Tiotropium Respimat(®) vs. HandiHaler(®): real-life usage and TIOSPIR trial generalizability.
about
Cardiovascular safety of tiotropium Respimat vs HandiHaler in the routine clinical practice: A population-based cohort studyResponse to Wise et al. (Tiotropium safety in real life populations).Tiotropium safety in 'real-world' populations: Response to Schmiedl, et al. in the British Journal of Clinical Pharmacology
P2860
Tiotropium Respimat(®) vs. HandiHaler(®): real-life usage and TIOSPIR trial generalizability.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Tiotropium Respimat(®) vs. Han ...... IOSPIR trial generalizability.
@ast
Tiotropium Respimat(®) vs. Han ...... IOSPIR trial generalizability.
@en
type
label
Tiotropium Respimat(®) vs. Han ...... IOSPIR trial generalizability.
@ast
Tiotropium Respimat(®) vs. Han ...... IOSPIR trial generalizability.
@en
prefLabel
Tiotropium Respimat(®) vs. Han ...... IOSPIR trial generalizability.
@ast
Tiotropium Respimat(®) vs. Han ...... IOSPIR trial generalizability.
@en
P2093
P2860
P356
P1476
Tiotropium Respimat(®) vs. Han ...... IOSPIR trial generalizability.
@en
P2093
Dominik Rottenkolber
Elena Ballarin
Joan Fortuny
Joerg Hasford
Marietta Rottenkolber
Martin Tauscher
Monica Sabaté
Petra Thürmann
Pili Ferrer
Rainald Fischer
P2860
P304
P356
10.1111/BCP.12808
P407
P50
P577
2015-10-27T00:00:00Z